These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 24889915)

  • 1. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
    Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
    Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring in cancer--are we missing a trick?
    Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
    Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
    Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
    Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target concentration intervention in oncology: where are we at?
    Saleem M; Dimeski G; Kirkpatrick CM; Taylor PJ; Martin JH
    Ther Drug Monit; 2012 Jun; 34(3):257-65. PubMed ID: 22585183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of cancer chemotherapy.
    Alnaim L
    J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring in cancer chemotherapy.
    Bach DM; Straseski JA; Clarke W
    Bioanalysis; 2010 May; 2(5):863-79. PubMed ID: 21083218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
    Marquet P; Rousseau A
    Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
    Prokopczyk J; Piekarczyk A; Kaminska E
    Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxics.
    Levêque D; Becker G
    Expert Opin Drug Saf; 2019 Nov; 18(11):1009-1015. PubMed ID: 31478396
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
    Rousseau A; Marquet P
    Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.
    Lee JW; Kang HJ; Lee SH; Yu KS; Kim NH; Yuk YJ; Jang MK; Han EJ; Kim H; Song SH; Park KD; Shin HY; Jang IJ; Ahn HS
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):944-50. PubMed ID: 22155501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.
    de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Pharmacokinet; 2005; 44(2):147-73. PubMed ID: 15656695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review.
    Maillard M; Le Louedec F; Thomas F; Chatelut E
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):907-925. PubMed ID: 33016786
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetically guided administration of chemotherapeutic agents.
    van den Bongard HJ; Mathôt RA; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2000 Nov; 39(5):345-67. PubMed ID: 11108434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology.
    Zandvliet AS; Schellens JH; Beijnen JH; Huitema AD
    Clin Pharmacokinet; 2008; 47(8):487-513. PubMed ID: 18611060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach.
    Hon YY; Evans WE
    Clin Chem; 1998 Feb; 44(2):388-400. PubMed ID: 9474050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications and challenges in therapeutic drug monitoring of cancer treatment: A review.
    Salman B; Al-Khabori M
    J Oncol Pharm Pract; 2021 Apr; 27(3):693-701. PubMed ID: 33302823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring.
    Takada M; Goto T; Kotake T; Saito M; Kawato N; Nakai M; Gunji T; Shibakawa M
    J Clin Pharm Ther; 2005 Feb; 30(1):5-12. PubMed ID: 15658999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.